Gillian Greig - Concepedia

Concepedia

Author

Gillian Greig

Merck Canada Inc. (Canada)

Also Known As

G Greig, G M Greig, G. GREIG, G. Greig, G. M. GREIG, G.M. Greig, Gillian Greig, Gillian M Greig, Gillian M. Greig, Greig, G.

50

Publications

4.8K

Citations

29

H-Index

51

Concepts

All Affiliations

Merck Canada Inc. (Canada)Merck & Co., Inc., Rahway, NJ, USA (United States)TransCanada (Canada)University of Toronto Stanford University

GG

About

Gillian Greig is an author at Merck Canada Inc. (Canada) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	29	3.4K
2	Natural Sciences	6	6	428
3	Engineering	1	1	28
4	Allergy	1	1	78
5	Allergy Medicine	1	1	78

Gillian Greig

×

36

Publications

4.8K

Citations

29

H-Index

	Year	Citations
Characterization of the human cysteinyl leukotriene CysLT1 receptor Kevin R. Lynch, Gary P. O’Neill, Qingyun Liu, Nature InflammationCytokineG Protein-coupled ReceptorMedicineImmunology	1999	967
Gene for von Recklinghausen Neurofibromatosis Is in the Pericentromeric Region of Chromosome 17 David Barker, E Wright, K. Nguyen, Science Mendelian DisorderGenetic DisorderGeneticsPathologyDefective Gene	1987	695
Uniparental disomy as a mechanism for human genetic disease. J. Edward Spence, R G Perciaccante, Gillian Greig, PubMed	1988	490
Etoricoxib (MK-0663): Preclinical Profile and Comparison with Other Agents That Selectively Inhibit Cyclooxygenase-2 Denis Riendeau, M. David Percival, Christine Brideau, Journal of Pharmacology and Experimental Therapeutics	2001	456
Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX‐2 inhibitor Denis Riendeau, M. David Percival, S. Boyce, British Journal of Pharmacology Pge2 ProductionChemoprevention StrategyImmunologyPharmacotherapyPharmaceutical Chemistry	1997	326
Discovery of a Potent and Selective Prostaglandin D<sub>2</sub> Receptor Antagonist, [(3<i>R</i>)-4-(4-Chloro- benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[<i>b</i>]indol-3-yl]-acetic Acid (MK-0524) Claudio F. Sturino, Gary P. O’Neill, Nicolas Lachance, Journal of Medicinal Chemistry	2007	170
2-Pyridinyl-3-(4-methylsulfonyl)phenylpyridines: Selective and orally active cyclooxygenase-2 inhibitors Richard W. Friesen, Christine Brideau, Chi Chung Chan, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryActive Cyclooxygenase-2 InhibitorsMedicineNatural Sciences	1998	128
Mechanism of selective inhibition of human prostaglandin G/H synthase-1 and -2 in intact cells Stacia Kargman, Elizabeth Wong, Gillian Greig, Biochemical Pharmacology Selective InhibitionMolecular PharmacologyIntact CellsMolecular PhysiologySignal Transduction	1996	110
PCR amplification of chromosome-specific alpha satellite DNA: Definition of centromeric STS markers and polymorphic analysis Peter E. Warburton, Gillian Greig, Thomas Haaf, Genomics ChromatinCentromeric Sts MarkersDna SequencingPcr AmplificationCytogenetics	1991	108
The C3a receptor antagonist SB 290157 has agonist activity Marie‐Claude Mathieu, Nicole Sawyer, Gillian Greig, Immunology Letters Functional SelectivityMedicineAgonist ActivityMechanism Of ActionReceptor (Biochemistry)	2005	92

Page 1